Cargando…

Humoral and T cell Responses to SARS-CoV-2 Vaccine Booster and Anti-SARS-CoV-2 Monoclonal Antibodies in Patients With End-Stage Kidney Disease

Detalles Bibliográficos
Autores principales: Zaza, Gianluigi, Stallone, Giovanni, Granata, Simona, Gentile, Micaela, Panico, Maddalena, Bin, Sofia, Wang, Lin, Rollenhagen, Christiane, Maltzman, Jonathan S., Cravedi, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148717/
https://www.ncbi.nlm.nih.gov/pubmed/37360818
http://dx.doi.org/10.1016/j.ekir.2023.04.026
_version_ 1785035032431165440
author Zaza, Gianluigi
Stallone, Giovanni
Granata, Simona
Gentile, Micaela
Panico, Maddalena
Bin, Sofia
Wang, Lin
Rollenhagen, Christiane
Maltzman, Jonathan S.
Cravedi, Paolo
author_facet Zaza, Gianluigi
Stallone, Giovanni
Granata, Simona
Gentile, Micaela
Panico, Maddalena
Bin, Sofia
Wang, Lin
Rollenhagen, Christiane
Maltzman, Jonathan S.
Cravedi, Paolo
author_sort Zaza, Gianluigi
collection PubMed
description
format Online
Article
Text
id pubmed-10148717
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-101487172023-05-01 Humoral and T cell Responses to SARS-CoV-2 Vaccine Booster and Anti-SARS-CoV-2 Monoclonal Antibodies in Patients With End-Stage Kidney Disease Zaza, Gianluigi Stallone, Giovanni Granata, Simona Gentile, Micaela Panico, Maddalena Bin, Sofia Wang, Lin Rollenhagen, Christiane Maltzman, Jonathan S. Cravedi, Paolo Kidney Int Rep Letter to the Editor Elsevier 2023-04-29 /pmc/articles/PMC10148717/ /pubmed/37360818 http://dx.doi.org/10.1016/j.ekir.2023.04.026 Text en © 2023 International Society of Nephrology. Published by Elsevier Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Letter to the Editor
Zaza, Gianluigi
Stallone, Giovanni
Granata, Simona
Gentile, Micaela
Panico, Maddalena
Bin, Sofia
Wang, Lin
Rollenhagen, Christiane
Maltzman, Jonathan S.
Cravedi, Paolo
Humoral and T cell Responses to SARS-CoV-2 Vaccine Booster and Anti-SARS-CoV-2 Monoclonal Antibodies in Patients With End-Stage Kidney Disease
title Humoral and T cell Responses to SARS-CoV-2 Vaccine Booster and Anti-SARS-CoV-2 Monoclonal Antibodies in Patients With End-Stage Kidney Disease
title_full Humoral and T cell Responses to SARS-CoV-2 Vaccine Booster and Anti-SARS-CoV-2 Monoclonal Antibodies in Patients With End-Stage Kidney Disease
title_fullStr Humoral and T cell Responses to SARS-CoV-2 Vaccine Booster and Anti-SARS-CoV-2 Monoclonal Antibodies in Patients With End-Stage Kidney Disease
title_full_unstemmed Humoral and T cell Responses to SARS-CoV-2 Vaccine Booster and Anti-SARS-CoV-2 Monoclonal Antibodies in Patients With End-Stage Kidney Disease
title_short Humoral and T cell Responses to SARS-CoV-2 Vaccine Booster and Anti-SARS-CoV-2 Monoclonal Antibodies in Patients With End-Stage Kidney Disease
title_sort humoral and t cell responses to sars-cov-2 vaccine booster and anti-sars-cov-2 monoclonal antibodies in patients with end-stage kidney disease
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148717/
https://www.ncbi.nlm.nih.gov/pubmed/37360818
http://dx.doi.org/10.1016/j.ekir.2023.04.026
work_keys_str_mv AT zazagianluigi humoralandtcellresponsestosarscov2vaccineboosterandantisarscov2monoclonalantibodiesinpatientswithendstagekidneydisease
AT stallonegiovanni humoralandtcellresponsestosarscov2vaccineboosterandantisarscov2monoclonalantibodiesinpatientswithendstagekidneydisease
AT granatasimona humoralandtcellresponsestosarscov2vaccineboosterandantisarscov2monoclonalantibodiesinpatientswithendstagekidneydisease
AT gentilemicaela humoralandtcellresponsestosarscov2vaccineboosterandantisarscov2monoclonalantibodiesinpatientswithendstagekidneydisease
AT panicomaddalena humoralandtcellresponsestosarscov2vaccineboosterandantisarscov2monoclonalantibodiesinpatientswithendstagekidneydisease
AT binsofia humoralandtcellresponsestosarscov2vaccineboosterandantisarscov2monoclonalantibodiesinpatientswithendstagekidneydisease
AT wanglin humoralandtcellresponsestosarscov2vaccineboosterandantisarscov2monoclonalantibodiesinpatientswithendstagekidneydisease
AT rollenhagenchristiane humoralandtcellresponsestosarscov2vaccineboosterandantisarscov2monoclonalantibodiesinpatientswithendstagekidneydisease
AT maltzmanjonathans humoralandtcellresponsestosarscov2vaccineboosterandantisarscov2monoclonalantibodiesinpatientswithendstagekidneydisease
AT cravedipaolo humoralandtcellresponsestosarscov2vaccineboosterandantisarscov2monoclonalantibodiesinpatientswithendstagekidneydisease